Avatar
Bite4flax

0 Following 0 Followers
1
Exposed to autoradiography film. High-mannose moieties were preserved only in untreated virus confirming that PNGase F and endo H effectively cleaved high-mannose residues on GPs of HIV-EBOV virion-like particles. (EPS) Figure S4 Thermolysin treatment of HIV-EBOV GP abrogates enhancement of infection by rhMBL in a thermolysin-concentration dependent manner. We preincubated HIV-EBOV GP virion-like
1
On of fetal calf or fetal bovine serum typically used for EBOV infectivity assays [17,18,44,45,67]. Given that C4 gene copy number variations may lead to a proportionate reduction ofLectin-Dependent Enhancement of Ebola Virusesiological doses of MBL products or blood products with high MBL concentrations to individuals in the setting of infectious diseases and relative hypocomplementemia may be de
1
Particles mixed withFigure 8. Proposed model of MBL-mediated macropinocytosis of EBOV. MBL carbohydrate recognition domains (CRD) bind to highly glycosylated mucin-rich regions of EBOV GP and the MBL-virion complex is presented to the cell surface. Then MBL binds to cognate cellular receptors, such as C1QBP or calreticulin [6] via MBL collagenous stalks. In this manner, MBL concentrates virus at t
1
Particles mixed withFigure 8. Proposed model of MBL-mediated macropinocytosis of EBOV. MBL carbohydrate recognition domains (CRD) bind to highly glycosylated mucin-rich regions of EBOV GP and the MBL-virion complex is presented to the cell surface. Then MBL binds to cognate cellular receptors, such as C1QBP or calreticulin [6] via MBL collagenous stalks. In this manner, MBL concentrates virus at t
1
Ge activity .500 U/mL (13/21 vs 1/ 14, p,0.005) compared with MBL2 O/O or O/A haplotypes (O refers to B,C or D alleles). (EPS) Figure S3 Endoglycosidases cleave N-linked glycans in HIV-EBOV GP. We preincubated HIV-EBOZ GP virion-like particles (12,000 pg/ml) with PNGase F or endo H (10,000 U/ml each) diluted in DMEM or with DMEM alone for 1 hour at 37uC. Viruses then underwent gel electrophoresis;
1
Ge activity .500 U/mL (13/21 vs 1/ 14, p,0.005) compared with MBL2 O/O or O/A haplotypes (O refers to B,C or D alleles). (EPS) Figure S3 Endoglycosidases cleave N-linked glycans in HIV-EBOV GP. We preincubated HIV-EBOZ GP virion-like particles (12,000 pg/ml) with PNGase F or endo H (10,000 U/ml each) diluted in DMEM or with DMEM alone for 1 hour at 37uC. Viruses then underwent gel electrophoresis;
1
Ge activity .500 U/mL (13/21 vs 1/ 14, p,0.005) compared with MBL2 O/O or O/A haplotypes (O refers to B,C or D alleles). (EPS) Figure S3 Endoglycosidases cleave N-linked glycans in HIV-EBOV GP. We preincubated HIV-EBOZ GP virion-like particles (12,000 pg/ml) with PNGase F or endo H (10,000 U/ml each) diluted in DMEM or with DMEM alone for 1 hour at 37uC. Viruses then underwent gel electrophoresis;
1
Infections using high level rhMBL (10 mg/ml) in 5 serum (i.e. diluted 20-fold). However, such a high concentration of rhMBL is considered supraphysiological if adjusted for the 20-fold dilution factor of serum. Although human MBL is produced primarily in the liver, extrahepatic MBL synthesis has been found in the gastrointestinal tract, middle ear fluid, and nasopharyngeal secretions. It is possi